These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25529571)

  • 1. Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.
    Vacas-Córdoba E; Climent N; De La Mata FJ; Plana M; Gómez R; Pion M; García F; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2014 Dec; 9(17):2683-702. PubMed ID: 25529571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis.
    Coelho AV; de Moura RR; Kamada AJ; da Silva RC; Guimarães RL; Brandão LA; de Alencar LC; Crovella S
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.
    Walsh SR; Bhardwaj N; Gandhil RT
    Curr HIV Res; 2003 Apr; 1(2):205-16. PubMed ID: 15043203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanochemistry-based immunotherapy for HIV-1.
    Lori F; Calarota SA; Lisziewicz J
    Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies.
    Córdoba EV; Pion M; Rasines B; Filippini D; Komber H; Ionov M; Bryszewska M; Appelhans D; Muñoz-Fernández MA
    Nanomedicine; 2013 Oct; 9(7):972-84. PubMed ID: 23506949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-based human immunodeficiency virus vaccine.
    Rinaldo CR
    J Intern Med; 2009 Jan; 265(1):138-58. PubMed ID: 19093966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting dendritic cells for improved HIV-1 vaccines.
    Smed-Sörensen A; Loré K
    Adv Exp Med Biol; 2013; 762():263-88. PubMed ID: 22975879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-antigens charged on phosphorus dendrimers as tools for tolerogenic dendritic cells-based immunotherapy.
    Vacas-Córdoba E; Bastida H; Pion M; Hameau A; Ionov M; Bryszewska M; Caminade AM; Majoral JP; Muñoz-Fernández MÁ
    Curr Med Chem; 2014; 21(16):1898-909. PubMed ID: 24304285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.
    García F; Routy JP
    Vaccine; 2011 Sep; 29(38):6454-63. PubMed ID: 21791232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dendritic cells in HIV-immunotherapy.
    Van Gulck E; Van Tendeloo VF; Berneman ZN; Vanham G
    Curr HIV Res; 2010 Jun; 8(4):310-22. PubMed ID: 20353393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.
    Cobb A; Roberts LK; Palucka AK; Mead H; Montes M; Ranganathan R; Burkeholder S; Finholt JP; Blankenship D; King B; Sloan L; Harrod AC; Lévy Y; Banchereau J
    J Immunol Methods; 2011 Feb; 365(1-2):27-37. PubMed ID: 21093448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.
    Surenaud M; Lacabaratz C; Zurawski G; Lévy Y; Lelièvre JD
    Expert Rev Vaccines; 2017 Oct; 16(10):955-972. PubMed ID: 28879788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
    Ahlers JD; Belyakov IM
    Trends Mol Med; 2009 Jun; 15(6):263-74. PubMed ID: 19487159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
    Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
    J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook.
    Mohamed H; Miller V; Jennings SR; Wigdahl B; Krebs FC
    J Immunol Res; 2020; 2020():9470102. PubMed ID: 32537473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for vaccine protection against HIV-1 infection and AIDS.
    Letvin NL; Barouch DH; Montefiori DC
    Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.